E-viri
Recenzirano
Odprti dostop
-
de Almeida Marques, Daisymara Priscila; Andrade, Luis Adan Flores; Reis, Erik Vinicius Sousa; Clarindo, Felipe Alves; Moraes, Thaís de Fátima Silva; Lourenço, Karine Lima; De Barros, Wellington Alves; Costa, Nathália Evelyn Morais; Andrade, Lídia Maria de; Lopes-Ribeiro, Ágata; Coêlho Maciel, Mariella Sousa; Corrêa-Dias, Laura Cardoso; de Almeida, Isabela Neves; Arantes, Thalita Souza; Litwinski, Vivian Costa Vasconcelos; de Oliveira, Leonardo Camilo; Serafim, Mateus Sá Magalhães; Maltarollo, Vinicius Gonçalves; Guatimosim, Silvia Carolina; Silva, Mário Morais; Tsuji, Moriya; Ferreira, Rafaela Salgado; Barreto, Luiza Valença; Barbosa-Stancioli, Edel Figueiredo; da Fonseca, Flávio Guimarães; De Fátima, Ângelo; Coelho-Dos-Reis, Jordana Grazziela Alves
Virus research, 02/2024, Letnik: 340Journal Article
Here, the antiviral activity of aminoadamantane derivatives were evaluated against SARS-CoV-2. The compounds exhibited low cytotoxicity to Vero, HEK293 and CALU-3 cells up to a concentration of 1,000 µM. The inhibitory concentration (IC ) of aminoadamantane was 39.71 µM in Vero CCL-81 cells and the derivatives showed significantly lower IC values, especially for compounds 3F4 (0.32 µM), 3F5 (0.44 µM) and 3E10 (1.28 µM). Additionally, derivatives 3F5 and 3E10 statistically reduced the fluorescence intensity of SARS-CoV-2 protein S from Vero cells at 10 µM. Transmission microscopy confirmed the antiviral activity of the compounds, which reduced cytopathic effects induced by the virus, such as vacuolization, cytoplasmic projections, and the presence of myelin figures derived from cellular activation in the face of infection. Additionally, it was possible to observe a reduction of viral particles adhered to the cell membrane and inside several viral factories, especially after treatment with 3F4. Moreover, although docking analysis showed favorable interactions in the catalytic site of Cathepsin L, the enzymatic activity of this enzyme was not inhibited significantly in vitro. The new derivatives displayed lower predicted toxicities than aminoadamantane, which was observed for either rat or mouse models. Lastly, in vivo antiviral assays of aminoadamantane derivatives in BALB/cJ mice after challenge with the mouse-adapted strain of SARS-CoV-2, corroborated the robust antiviral activity of 3F4 derivative, which was higher than aminoadamantane and its other derivatives. Therefore, aminoadamantane derivatives show potential broad-spectrum antiviral activity, which may contribute to COVID-19 treatment in the face of emerging and re-emerging SARS-CoV-2 variants of concern.
Avtor
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Vir: Osebne bibliografije
in: SICRIS
To gradivo vam je dostopno v celotnem besedilu. Če kljub temu želite naročiti gradivo, kliknite gumb Nadaljuj.